Paralysis News and Research

RSS

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.

Now revealed that Salk polio vaccine was a team effort

The cure for polio came as a result of the collaboration between Thomas Francis Jr. and Jonas Salk.

10 Apr 2005

Clinical study of mirror neurons provides insights into autism and other disorders

Seeing is doing – at least it is when mirror neurons are working normally. But in autistic individuals, say researchers from the University of California, San Diego, the brain circuits that enable people to perceive and understand the actions of others do not behave in the usual way.

29 Mar 2005

Eating seafood containing toxic substances can have serious neurological as well as gastrointestinal effects

In parts of the Pacific, the number of cases of marine poisoning exceeds 1200 per 100 000 people per year. Although most of the burden of marine poisoning is in rural coastal communities, many people who live outside these communities, or travel to them, are presenting to their doctors with acute or ongoing effects after eating seafood.

21 Mar 2005

Doctors may soon be able to diagnose multiple sclerosis (MS) with a simple blood test

New research by Wake Forest University Baptist Medical Center and colleagues suggests that one day, doctors may be able to diagnose multiple sclerosis (MS) with a simple blood test. The findings are reported in the current issue of the Journal of Molecular Neuroscience.

15 Mar 2005

Gene therapy helps Lou Gehrig's disease

The most common form of motor neurone disease, called amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, is caused when neurones in the spinal cord die, leading to muscle wasting and total paralysis.

14 Mar 2005

RNA interference as promising therapy for ALS

Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS), substantially delaying both the onset and the progression rate of the fatal motor neuron disease.

13 Mar 2005

Fear of botulism as a bioterrorist weapon is to be reduced by British vaccine technology

Fear of botulism as a bioterrorist weapon is to be reduced, as the US government announces its support for a new British vaccine technology, which promises for the first time to provide an effective defence against botulism – the most deadly naturally occurring substance.

28 Feb 2005

Potential treatments for neurofibromatosis

Scientists at the Indiana University School of Medicine are closing in on potential treatments for neurofibromatosis, a genetic disease that afflicts 100,000 Americans with nerve tissue tumors, some of which become cancerous.

3 Feb 2005

Antibiotics protect nerves in mice by turning on genes

A family of antibiotics that includes penicillin may help prevent nerve damage and death in a wide variety of neurological diseases, including Lou Gehrig's disease, dementia, stroke, and epilepsy, Johns Hopkins researchers have found.

6 Jan 2005

New clue to nerve growth may help regeneration efforts

Johns Hopkins scientists have discovered how one family of proteins repels growing nerves and keeps them properly on track during development.

16 Dec 2004

Landmark campaign, intends to help one million children under-five fight measles, polio and malaria

In the first nationwide campaign of its kind, Togo’s children will receive four life-saving interventions at once. The landmark campaign, launched today, intends to reach one million children under-five with vaccines to prevent measles and polio, mosquito nets to prevent malaria and deworming tablets.

14 Dec 2004

Findings could lead to new knowledge that could speed the development of drugs to block botulism or tetanus toxins more rapidly

The first detailed structure of a botulism toxin attached to its target protein reveals that the toxin snakes the protein around itself — a sort of “reverse anaconda” — to recognize the receptor.

13 Dec 2004

Helping to heal complications from spinal cord injury

A London scientist has received a major grant to help improve the quality of life for individuals with spinal cord injuries.

8 Dec 2004

Method for healing spinal injuries in dogs offers hope for preventing human paralysis

Lab tests have shown that an injection of a liquid polymer known as polyethylene glycol (PEG), if administered within 72 hours of serious spinal injury, can prevent most dogs from suffering permanent spinal damage.

3 Dec 2004

People suffering from paralysis may be able to reprogram their brains to improve motor skills and to control artificial limbs

People suffering from paralysis due to stroke or traumatic brain injury may be able to reprogram their brains to improve motor skills and to control artificial limbs, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

New research may lead to new treatments for spinal cord injury and multiple sclerosis

For the first time, researchers have used human embryonic stem cells to create new insulating tissue for nerve fibers in a live animal model – a finding that has potentially important implications for treatment of spinal cord injury and multiple sclerosis.

23 Nov 2004

Paralysis News and Research

Further Reading